StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.14−0.10 (-4.46%)

Close on Nov 17, 2026Market cap $4.83MP/E –Yield –

Biodexa Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2017 it was 674.6%, against 472.9% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2017Dec 31, 2017674.6%+201.8
FY2016Dec 31, 2016472.9%+378.0
FY2015Dec 31, 201594.9%–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?